Clínic Barcelona

Launch of DIRECT, an Innovative Medicines Initiative Project for Personalized Medicine in Diabetes

DIRECT (DIabetes REsearCh for patient straTification), a consortium funded by the Innovative Medicines Initiative (IMI), announced today the launch of a 45 million Euro project focusing on a stratification of patients with diabetes. Scientists and clinicians working in academia have joined forces with the pharmaceutical industry to tackle the current bottlenecks in diabetes drug development and to develop a personalized medicines approach to treatment of ‘type 2 diabetes’ (T2D) with either existing or novel therapies.